As a result, p53 acetylation was increased without altering total p53 expression in CCl4-induced liver fibrosis rats, and SRT1720 treatment reversed this change, leading to a decrease in acetylated p53 levels (Fig 2B). This evidence concerns the gene TP53 and Hepatic fibrosis.